Patents by Inventor Bruno Lunenfeld

Bruno Lunenfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kit for use in treatment of polycystic ovarian disease
    Patent number: 6492177
    Abstract: Agents which increase the levels of human insulin-like growth factor-1 binding protein (h-ICFBP-1), such as an estrogen, are used in conjunction with a gonadotropin releasing hormone (GnRH) analogue in the treatment of PCOD and associated infertility.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: December 10, 2002
    Assignee: Applied Research Systems ARS Holding NV
    Inventor: Bruno Lunenfeld
  • Treatment of polycystic ovarian disease
    Patent number: 6489288
    Abstract: Agents which increase the levels of human insulin-like growth factor—1 binding protein (h-IGFBP-1), such as an estrogen, are used in conjunction with a gonadotropin releasing hormone (GnRH) analogue in the treatment of PCOD and associated infertility.
    Type: Grant
    Filed: February 16, 1994
    Date of Patent: December 3, 2002
    Assignee: Applied Research Systems ARS Holding
    Inventor: Bruno Lunenfeld
  • Management of infertility
    Patent number: 5175111
    Abstract: A method for determining whether an infertile patient is likely to benefit from combined GH/gonadotropin or GHRH/gonadotropin therapy comprising the steps of (1) administering a predetermined dose of clonidine or a pharmaceutically acceptable derivative thereof to the patient; (2) monitoring the blood level of GH following the administration of clonidine or a derivative thereof; and (3) detecting whether the peak blood level of GH is above a predetermined level.
    Type: Grant
    Filed: October 1, 1990
    Date of Patent: December 29, 1992
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Bruno Lunenfeld, Yeheskel Menashe